Dec 21,2021

Ciba Health Announces Partnership with Friendship Senior Options

Ciba Health, a virtual healthcare provider, has announced its partnership with Friendship Senior Options, a retirement and assisted-living facility in Schaumburg, Illinois. Ciba’s Type 2 Diabetes Reversal program will be made available to all eligible associates of Friendship, granting access to a team of holistic practitioners.

COLLABORATION PARTNERSHIP

#product & service

#dtx

View Analyst & Ambassador Comments
Go to original news
Dec 21,2021

DarioHealth Selected as Exclusive Digital Therapeutics Provider to a Leading Benefits Brokerage

DarioHealth Corp., a leader in the global digital therapeutics (DTx) market, announced a new strategic partnership with a leading employer benefits brokerage to sell its digital therapeutic solutions for diabetes, hypertension and musculoskeletal health as part of a new premier employee health benefits product for small businesses. The product will be made available to the Partner’s more than 2,300 clients beginning in early 2022.

#dtx

View Analyst & Ambassador Comments
Go to original news
Dec 21,2021

Eversense NOW Remote Monitoring App for Android Users Receives CE Mark in Europe

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced it received CE mark of the Eversense® NOW Remote Monitoring App for the Android Operating System. The Eversense NOW iOS platform has previously been approved and is currently available in Europe.

REGULATORY CE MARK

#cgm

#rpm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 21,2021

BD Announces Board of Directors for embecta, the Planned Spinoff of its Diabetes Care Business

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Embecta Corp. ("embecta"), the independent, publicly-traded company that will hold BD's Diabetes Care business upon the planned completion of the previously announced spinoff, will be governed by a nine-person board of directors.

View Analyst & Ambassador Comments
Go to original news
Dec 21,2021

Indigo Diabetes Business Update

Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, today provides an update on recent and ongoing business activities.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 22,2021

CMS expands diabetes Medicare coverage to include CGMs that integrate with Medtronic insulin pumps

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) will expand Medicare coverage for all types of continuous glucose monitors (CGMs), including adjunctive and non-adjunctive CGMs. This includes CGMs that integrate with Medtronic insulin pumps. The proposed rule was finalized on December 21, 2021 and will be effective starting 60 days after official publication.

PRODUCT

#cgm

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Dec 26,2021

The Effectiveness of Telemedicine Solutions for the Management of Type 2 Diabetes: A Systematic Review, Meta-Analysis, and Meta-Regression

Previous systematic reviews have aimed to clarify the effect of telemedicine on diabetes. However, such reviews often have a narrow focus, which calls for a more comprehensive systematic review within the field. Hence, the objective of the present systematic review, meta-analysis, and meta-regression is to evaluate the effectiveness of telemedicine solutions versus any comparator without the use of telemedicine on diabetes-related outcomes among adult patients with type 2 diabetes (T2D).

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Dec 26,2021

Clinical Practice Experiences Using a Professional Diabetes Management Ecosystem During COVID

Challenges of patient care in diabetes were exacerbated by COVID, undermining the ability of patients to engage in-person with health care professionals (HCPs). To combat this, there has been accelerated adoption of telemedicine to support patient and provider connectivity. This study has concluded that diabetes management solutions, such as OneTouchReveal ecosystem, supported telemedicine during the pandemic and will continue to play a valuable role in patient care beyond the pandemic.

CLINICAL STUDY

#telehealth

View Analyst & Ambassador Comments
Go to original news
Dec 27,2021

When medicine is the hero, you need a Sidekick to stay the course

With so many health issues stemming from lifestyle-related illnesses, it’s no surprise that one of the biggest aspects of the modern lifestyle may be part of the cure. Sidekick Health uses digital therapeutics (DTx), behavioral economics combined with artificial intelligence and gamification elements such as charity rewards to help patients adapt their behavior and stick to medical treatment plans—all on their smartphones. Starting with cardiovascular and metabolic conditions, Sidekick now works across 40 therapeutic areas including oncology, diabetes and rheumatoid arthritis.

View Analyst & Ambassador Comments
Go to original news
Jan 07,2020

Paris-based PKvitality snaps up €2.25 million to develop smartwatch for diabetes management

PKvitality, a French startup specialized in bio wearables, has snapped up €2.25 million via an agreement with Beurer GmBH, the German medical product and well-being company.

FUNDING SEED
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES